These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16998561)

  • 1. [Warfarin treatment in atrial fibrillation].
    Meland E
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2409; author reply 2409-10. PubMed ID: 16998561
    [No Abstract]   [Full Text] [Related]  

  • 2. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulation for atrial fibrillation.
    Greiver M
    Can Fam Physician; 2005 Dec; 51(12):1629. PubMed ID: 16805080
    [No Abstract]   [Full Text] [Related]  

  • 4. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.
    Morgan SV
    Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835
    [No Abstract]   [Full Text] [Related]  

  • 5. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 6. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
    Quinn RR; Naimark DM; Oliver MJ; Bayoumi AM
    Am J Kidney Dis; 2007 Sep; 50(3):421-32. PubMed ID: 17720521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of warfarin use with osteoporotic fracture in elderly patients with atrial fibrillation.
    Cheng HY
    Arch Intern Med; 2006 Jul; 166(14):1525; author reply 1525. PubMed ID: 16864765
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of long-term warfarin on the quality of life of elderly people with atrial fibrillation.
    Das AK; Willcoxson PD; Corrado OJ; West RM
    Age Ageing; 2007 Jan; 36(1):95-7. PubMed ID: 16799180
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation anticoagulants may push warfarin to the wayside.
    Kirsch B
    Manag Care; 2011 Feb; 20(2):33-6. PubMed ID: 21428128
    [No Abstract]   [Full Text] [Related]  

  • 11. Rethinking warfarin for atrial fibrillation.
    Med Lett Drugs Ther; 2013 Sep; 55(1426):77. PubMed ID: 24081386
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistence with therapy among patients treated with warfarin for atrial fibrillation.
    Gomes T; Mamdani MM; Holbrook AM; Paterson JM; Juurlink DN
    Arch Intern Med; 2012 Nov; 172(21):1687-9. PubMed ID: 23090098
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tay KH; Lip GY; Lane DA
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):392-3. PubMed ID: 19542940
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ximelagatran cannot be an alternative to standard warfarin therapy in chronic atrial fibrillation/ antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Cavuşoğlu Y
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):217-8; author reply 218-9. PubMed ID: 17513231
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 16. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T
    Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival benefit of new anticoagulants compared with warfarin in patients with atrial fibrillation: a meta-analysis.
    Liu T; Korantzopoulos P; Li L; Li G
    Int J Cardiol; 2012 Apr; 156(1):96-7. PubMed ID: 22257690
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulation in the octogenarian with atrial fibrillation.
    Kapoor M; McNicoll L
    Med Health R I; 2009 Apr; 92(4):152-4. PubMed ID: 19452760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticoagulation treatment in atrial fibrillation].
    Raeder H; Kildahl-Andersen O
    Tidsskr Nor Laegeforen; 2002 Feb; 122(6):651. PubMed ID: 11998724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.